#AstraZeneca

Tulika Singh, MPH

singh_tulika

Colleagues in #science – thank you for your efforts in developing life-saving technologies/knowledge. Though many of our innovations depend on patents to move from bench to society, this crisis demands

Sizwe sikaMusi

SizweLo

Since we're all going to be vaccinated soon (some against their will), it is only proper that we understand what vaccines are, what they do and how they do it.

Liz Szabo

LizSzabo

LIVE: Operation Warp Speed's Moncel Slaoui said @modernatx vaccine has efficacy of 94.1% overall, 87% efficacy in preventing moderate disease in adults over 65, 100% effective at preventing severe disease

𝙲𝙾𝙼𝙱𝙰𝚃𝙻𝚅𝙻 ⚖️

CombatLVL

https://www.israelnationalnews.com/News/News.aspx/293865 https://ussanews.com/News1/2020/12/30/watch-live-first-vaccine-death-reported-as-millions-of-doses-are-distributed-in-america/ https://www.reuters.com/article/us-health-coronavirus-sw

Charlie Haynes

charliehtweets

Some good news: it looks like the Oxford vaccine may both substantially reduce transmission AND reduces symptomatic infections in people who've had just a single dose for 3 months -

Adam John Ritchie

adamjohnritchie

I was involved in getting the #oxfordvaccine @JennerInstitute manufacturing process and consortium up and running. Here is a thread of why there is an issue with doses, with some science

Barrister's Horse

BarristersHorse

thread:The AZ/EU Contract. 1. This thread will all be pie in the sky if, as reported, the EU has failed to make the necessary down payments mentioned in my previous

Mac n’ Chise 🧬🧫🦠

sailorrooscout

It is important to point out that the Oxford/AstraZeneca vaccine is effective against the B.1.1.7 variant and reduces virus shedding and transmission. With this most likely being the dominate strain,

BiteBack

IHearTheShofar

INTERESTING: I was typing this and it DISAPPEARED.I have only 3K followers and no matter how many follow me, it never increases.SO IF YOU HAVE MORE, YOU MIGHT WANT TO

John Lichfield

john_lichfield

Something has been bugging me for days about the French Covid vaccination programme. The published figures don’t add up. They don’t explain why France has local shortages of vaccines and

Dave Keating

DaveKeating

Stick: "AZ gave different explanations in less than a week why there is a shortage of supply on the European continent and why they want to deliver only 31

Jim Reed

jim_reed

AstraZeneca responding to reports in Germany that Oxford vaccine might only be approved for under 65s: “Reports that efficacy is as low as 8% in adults over 65 are completely

William Wall will be happy to take the vaccine

williamwallbook

THREAD I was really excited about the Oxford/Astrazeneca vaccine at the start, mainly because of commitment from the Oxford group to sell the vaccine at close to cost to developed

Hilda Bastian, PhD

hildabast

Confirmation on the 78% for mild Covid-19 subgroup for Sinovac's inactivated vaccine CoronaVac: excluded people who didn't need medical care. Overall efficacy likely in the low 60s https://archive.vn/Ms4nM Depending on

Frances Smith

francessmith

This is an extract from an article I just RTd (link below) it deals with what I've trying to argue about most of today. The UK made an upfront payment

Niko Jaakkola

NikoEcon

Has the EU failed in its Covid vaccine programme? Thread.Progress slow; US 9% of population vaccinated; EU 3% (but only 3 weeks behind!). Some countries doing better (Israel 55%, UK

By continuing to use the site, you are consenting to the use of cookies as explained in our Cookie Policy to improve your experience.